While preliminary tests found low levels of the nitrosamine impurity N-nitrosodimethylamine (NDMA) in some ranitidine products, the FDA said this does not mean patients taking the drugs should stop using them now....

Comment

Become a member to take advantage of more features, like commenting and voting.

Jobs to Watch